Holden Leads Blog
Data, outreach strategies, and market intelligence for cannabis B2B professionals.
Two significant pieces of research published and amplified this week highlight those gaps from opposite ends of the scientific spectrum: one probing the plant's deepest molecular chemistry, the other examining how real people are actually making decisions about using it. Together, they illuminate both how much we've learned and how much remains unknown.
Read more →The ink on the most consequential federal cannabis policy shift in a generation is barely dry, and the industry is already sorting itself into winners, fast movers, and skeptics.
Read more →Over the past few years, THCA flower — technically hemp under the 2018 Farm Bill's delta-9-only testing standard — became one of the fastest-growing consumer product categories in the country, built on a legal interpretation that allowed high-potency cannabis to be sold nationwide without a dispensary license. This week, the federal government made its clearest statement yet that the gray market's golden age is drawing to a close.
Read more →The same week that cannabis made federal history, Congress reminded the industry just how complicated federal policy can be: as marijuana's rescheduling moved from executive order to law of the land, the U.S. House of Representatives passed a Farm Bill that would fundamentally rewrite the rules for the booming hemp-derived THC market — and not in the direction that industry hoped.
Read more →For years, cannabis operators have been paying more in federal taxes than almost any other industry in America — not because they're unusually profitable, but because of a single line in the tax code that forbids businesses trafficking in Schedule I controlled substances from deducting normal operating expenses.
Read more →The data from this year's holiday week, combined with a handful of notable launches that landed just before or during it, paints a picture of an industry that is maturing in real time: less novelty, more intentionality, and a consumer base that increasingly knows exactly what it wants.
Read more →Two product stories dominated the cannabis space this week, and they couldn't be more different. One involves a Canadian LP crafting ultra-premium, liquid diamond-infused flower for consumers who have, in the company's own framing, already exhausted everything else. The other involves a hemp-derived CBD company positioning its products for elderly Medicare beneficiaries managing chronic conditions. Taken separately, they're interesting brand launches. Taken together, they reveal something meanin
Read more →A landmark study published this week is now forcing a more honest conversation about what the science actually says.
Read more →The reallity of rescheduling is not what it seems, and will not be as fast as it sounds.
Read more →Holden Leads
Phone, email, website and licence data for dispensaries, cultivators, manufacturers, distributors and labs, verified weekly against state regulators.